You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency, look for clinical trials, and connect with others living with it — all in one place.
Open the full Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency hub →Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency is a rare condition. Also known as P5N deficiency, UMPH1 deficiency, Uridine 5'-monophosphate hydrolase deficiency. Tomeko brings together the specialists, research, clinical trials, treatments and community for Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:35120 · OMIM 266120 · ICD-10 D55.3 · GARD 0016635
Start by learning the basics from an authoritative source, find a specialist or center that sees Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency, and connect with a patient organization. Tomeko brings these together on one hub.
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency, filtered to your area.
Tomeko shows live, recruiting studies for Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency from ClinicalTrials.gov on the hub.